179 related articles for article (PubMed ID: 18364247)
1. Molecular and genetic changes in asbestos-related lung cancer.
Nymark P; Wikman H; Hienonen-Kempas T; Anttila S
Cancer Lett; 2008 Jun; 265(1):1-15. PubMed ID: 18364247
[TBL] [Abstract][Full Text] [Related]
2. The molecular epidemiology of asbestos and tobacco in lung cancer.
Nelson HH; Kelsey KT
Oncogene; 2002 Oct; 21(48):7284-8. PubMed ID: 12379872
[TBL] [Abstract][Full Text] [Related]
3. Identification of specific gene copy number changes in asbestos-related lung cancer.
Nymark P; Wikman H; Ruosaari S; Hollmén J; Vanhala E; Karjalainen A; Anttila S; Knuutila S
Cancer Res; 2006 Jun; 66(11):5737-43. PubMed ID: 16740712
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer.
Nymark P; Kettunen E; Aavikko M; Ruosaari S; Kuosma E; Vanhala E; Salmenkivi K; Pirinen R; Karjalainen A; Knuutila S; Wikman H; Anttila S
Clin Cancer Res; 2009 Jan; 15(2):468-75. PubMed ID: 19147751
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro.
Ruosaari ST; Nymark PE; Aavikko MM; Kettunen E; Knuutila S; Hollmén J; Norppa H; Anttila SL
Carcinogenesis; 2008 May; 29(5):913-7. PubMed ID: 18339684
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer.
Wikman H; Ruosaari S; Nymark P; Sarhadi VK; Saharinen J; Vanhala E; Karjalainen A; Hollmén J; Knuutila S; Anttila S
Oncogene; 2007 Jul; 26(32):4730-7. PubMed ID: 17297452
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
Neri M; Ugolini D; Dianzani I; Gemignani F; Landi S; Cesario A; Magnani C; Mutti L; Puntoni R; Bonassi S
Mutat Res; 2008; 659(1-2):126-36. PubMed ID: 18420450
[TBL] [Abstract][Full Text] [Related]
8. New insights on oxidative stress in cancer.
Visconti R; Grieco D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
[TBL] [Abstract][Full Text] [Related]
9. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers in risk assessment of asbestos exposure.
Bhattacharya K; Dopp E; Kakkar P; Jaffery FN; Schiffmann D; Jaurand MC; Rahman I; Rahman Q
Mutat Res; 2005 Nov; 579(1-2):6-21. PubMed ID: 16112146
[TBL] [Abstract][Full Text] [Related]
11. Reactive species: a cell damaging rout assisting to chemical carcinogens.
Goetz ME; Luch A
Cancer Lett; 2008 Jul; 266(1):73-83. PubMed ID: 18367325
[TBL] [Abstract][Full Text] [Related]
12. Modulation of oxidative DNA damage repair by the diet, inflammation and neoplastic transformation.
Tudek B; Swoboda M; Kowalczyk P; Oliński R
J Physiol Pharmacol; 2006 Nov; 57 Suppl 7():33-49. PubMed ID: 17228095
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress, DNA damage and repair in carcinogenesis: have we established a connection?
Georgakilas AG
Cancer Lett; 2012 Dec; 327(1-2):3-4. PubMed ID: 22484468
[TBL] [Abstract][Full Text] [Related]
14. Predisposing factors in occupational lung cancer: inorganic minerals and chromium.
Ding M; Shi X; Castranova V; Vallyathan V
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):129-38. PubMed ID: 10905518
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles.
Albrecht C; Borm PJ; Unfried K
Mutat Res; 2004 Sep; 553(1-2):23-35. PubMed ID: 15288530
[TBL] [Abstract][Full Text] [Related]
16. Metal-induced carcinogenesis, oxidative stress and hypoxia signalling.
Galanis A; Karapetsas A; Sandaltzopoulos R
Mutat Res; 2009 Mar; 674(1-2):31-5. PubMed ID: 19022395
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure.
Rostila A; Puustinen A; Toljamo T; Vuopala K; Lindström I; Nyman TA; Oksa P; Vehmas T; Anttila SL
Lung Cancer; 2012 Aug; 77(2):450-9. PubMed ID: 22537621
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
[TBL] [Abstract][Full Text] [Related]
19. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo.
Sullivan DE; Ferris M; Pociask D; Brody AR
J Immunotoxicol; 2008 Apr; 5(2):145-9. PubMed ID: 18569384
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
